Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302207 · ClinicalTrials.gov registry record · NA
The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 20,000
- Enrollment target
NCT04302207: Completed NA study, sponsored by University of Colorado, Denver.
NCT04302207 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 20,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1326% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04302207, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,000 participants
- Enrollment target
Study Summary
Over-testing and over-treatment costs the US healthcare system hundreds of billions of dollars a year, and has measurable negative impacts on patients' physical, emotional, and financial health making it a significant public health concern. The proposed research will advance "de-implementation" science by identifying processes and strategies to stop or reduce over-testing and over-treatment that can be broadly adapted to varied contexts and disease processes to improve the delivery of guideline concordant, evidence-based care and improve patient outcomes.
Primary Outcome
Online surveys will be given to providers care team members that experience the de-implementation strategies at the high-use hospitals to determine acceptability and appropriateness
Interventions
- BEHAVIORAL De-implementation Strategy for Bronchiolitis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT04302207 record still lists
NCT04302207 is an interventional study that assigns participants to a tested intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1326% higher).
The record links to 0 conditions, and to 1 intervention - of which De-implementation Strategy for Bronchiolitis is the first listed.
NCT04302207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04302207 about?
NCT04302207 is a clinical study titled "The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study". Over-testing and over-treatment costs the US healthcare system hundreds of billions of dollars a year, and has measurable negative impacts on patients' physical, emotional, and financial health making it a significant public health concern. The proposed research will advance "de-implementation" scie...
What is the current status of trial NCT04302207?
This trial is currently completed. It is a NA study. The enrollment target is 20,000 participants. The study started on 2020-09-01. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04302207?
The interventions under investigation include: De-implementation Strategy for Bronchiolitis (BEHAVIORAL).
Who is sponsoring clinical trial NCT04302207?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04302207's enrollment target sits among peer trials
20,000 11th of 2000 higher than 1,990 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI